Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience (Q46226514)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2008

edit

Language	Label	Description	Also known as
English	Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience	scientific article published in October 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

title

Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

main subject

pneumonia

1 reference

based on heuristic

inferred from title

levofloxacin

1 reference

based on heuristic

inferred from title

author name string

N Dartois

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

N Castaing

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

H Gandjini

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

A Cooper

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

Tigecycline 313 Study Group

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

publication date

1 October 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

published in

Journal of Chemotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

volume

20 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

page(s)

28-35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

cites work

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Guidelines for the management of adult lower respiratory tract infections

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Comparative antimicrobial susceptibility of respiratory tract pathogens

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Fluoroquinolone treatment of community-acquired pneumonia: a meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1179%2FJOC.2008.20.SUPPLEMENT-1.28

retrieved

21 January 2018

Identifiers

DOI

10.1179/JOC.2008.20.SUPPLEMENT-1.28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

PubMed publication ID

19036672

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19036672

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19036672

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46226514&oldid=2100487303"